Lennart .johansson
healthcare
BONESUPPORT
Sweden
Biography
Mr. Patrick T. O'Donnell serves as General Manager and Executive Vice President of International Commercial Operations - US at Bonesupport Holding AB. Mr. O’Donnell has been Executive Vice President of North American Commercialization and General Manager of BONESUPPORT AB since November 7, 2016. Mr. O'Donnell served as the Chief Executive Officer of ProChon Biotech Ltd. Mr. O'Donnell was the Co-Founder and Chief Executive Officer of ProteoThera Inc. He served as the Chief Executive Officer and President of Histogenics Corporation since May 2011 until March 5, 2013. Prior to Prochon Biotech, Mr. O’Donnell led the marketing organization for biomaterial start-up Confluent Surgical, Inc. Prior to Confluent Surgical, Mr. O’Donnell spent thirteen years at Johnson & Johnson’s DePuy Spine in Sales, Sales Management, Marketing and Management escalating positions of responsibility. He serves as a Director of ProChon Biotech Ltd. He served as a Director of Histogenics Corporation since May 2011 until March 5, 2013. He holds a BA from University of Wisconsin, US. Mr. Patrick T. O'Donnell serves as General Manager and Executive Vice President of International Commercial Operations - US at Bonesupport Holding AB. Mr. O’Donnell has been Executive Vice President of North American Commercialization and General Manager of BONESUPPORT AB since November 7, 2016. Mr. O'Donnell served as the Chief Executive Officer of ProChon Biotech Ltd. Mr. O'Donnell was the Co-Founder and Chief Executive Officer of ProteoThera Inc. He served as the Chief Executive Officer and President of Histogenics Corporation since May 2011 until March 5, 2013. Prior to Prochon Biotech, Mr. O’Donnell led the marketing organization for biomaterial start-up Confluent Surgical, Inc. Prior to Confluent Surgical, Mr. O’Donnell spent thirteen years at Johnson & Johnson’s DePuy Spine in Sales, Sales Management, Marketing and Management escalating positions of responsibility. He serves as a Director of ProChon Biotech Ltd. He served as a Director of Histogenics Corporation since May 2011 until March 5, 2013. He holds a BA from University of Wisconsin, US.
Research Interest
Healthcare